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Background For the detection of respiratory pathogens, the
sampling strategy may influence the diagnostic yield. Ideally,
samples from the lower respiratory tract are collected, but they are
difficult to obtain.
Objectives In this study, we compared the diagnostic yield in
sputum and oropharyngeal samples (OPS) for the detection of
respiratory pathogens in patients with community-acquired
pneumonia (CAP), with the objective to optimize our diagnostic
testing algorithm.
Methods Matched sputum samples, OPS, blood cultures, serum,
and urine samples were taken from patients (>18 years) with CAP
and tested for the presence of possible respiratory pathogens using
bacterial cultures, PCR for 17 viruses and five bacteria and urinary
antigen testing.
Results When using only conventional methods, that is, blood
cultures, sputum culture, urinary antigen tests, a pathogen was
detected in 496% of patients (n = 57). Adding molecular
detection assays increased the yield to 80%. A pathogen was
detected in 77 of the 115 patients in OPS or sputum samples by
PCR. The sensitivity of the OPS was lower than that of the sputum
samples (57% versus 74%). In particular, bacterial pathogens were
more often detected in sputum samples. The sensitivity of OPS for
the detection of most viruses was higher than in sputum samples
(72% versus 66%), except for human rhinovirus and respiratory
syncytial virus.
Conclusion Addition of PCR on both OPS and sputum samples
significantly increased the diagnostic yield. For molecular detection
of bacterial pathogens, a sputum sample is imperative, but for
detection of most viral pathogens, an OPS is sufficient.
Keywords Community-acquired pneumonia, oropharyngeal swabs,
real-time PCR, respiratory virus, sputum samples, yield.
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Introduction
Community-acquired pneumonia (CAP) remains a major
cause of morbidity and mortality worldwide.1 Streptococcus
pneumoniae, Mycoplasma pneumoniae, influenza A virus
(InfA), respiratory syncytial virus (RSV), and adenoviruses
(AdV) are recognized as important causes of CAP.2,3 Despite
efforts to find evidence for bacterial and viral pathogens as
etiological agents in patients with CAP, etiology remains
elusive in up to 50% of the patients.1,3–5 Reasons reported for
this low yield are use of antibiotics before collecting samples,
sample type tested, and the diagnostic panel used for patient
evaluation.6–8 Diagnostic methods used range from culture
(sputum, blood, throat swabs), antigen testing (e.g. urinary
antigen testing), and molecular tests. Some studies question
the value of bacterial sputum culture findings.8–10 Further-
more, serologic testing requires convalescent-phase samples,
and therefore, it is not useful in the initial phase of
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determining the etiology. Blood cultures provide a microbi-
ological diagnosis in 0–17%, and the addition of urinary
antigen detection assays for S. pneumoniae and Legionella
pneumophila has improved the yield substantially.3,11 During
the past years, PCR has been developed for many viral and
bacterial pathogens, resulting again in higher diagnostic
yields.12 Knowledge of the probable etiological agent(s) may
inform treatment, thereby potentially reducing the use of
antibiotics and eventually that of antimicrobial resistance.10
In this study, we aimed to assess the added value of viral
and bacterial molecular diagnostics on oropharyngeal swabs
(OPS) in comparison with sputum samples for the diagnosis
of CAP.
Materials and methods
Study design
This study was embedded within a larger prospective,
observational cohort study performed between April 2008
and March 2009. All patients with CAP aged 18 years and
older attending the emergency ward of two teaching hospitals
in Tilburg, the Netherlands, with the suspicion of CAP were
included. CAP was defined as the presence of a new or
progressive infiltrate on a chest radiograph with clinical
symptoms suggestive of a lower respiratory tract infection.
Exclusion criteria were (i) recent hospitalization (<2 weeks)
or residence in long-term care facilities, (ii) known bronchial
obstruction or a history of post-obstructive pneumonia (with
exception of chronic obstructive pulmonary disease), (iii)
primary lung cancer or another malignancy metastatic to the
lungs, (iv) AIDS, known or suspected Pneumocystis jirovecii
pneumonia, and (v) known or suspected active tuberculosis.
A case report form was obtained from all patients to
collect data on age, gender, current smoking, comorbidity,
clinical symptoms, prior antimicrobial treatment at admis-
sion, and blood analysis.
Sample collection, processing, and storage
According to protocol, at the emergency ward an OPS, a
sputum sample, urine sample, and a serum sample were
taken and two sets of blood samples were obtained. For this
comparative evaluation, only patients for whom a complete
sample set was available were included. Blood and urine
specimens were processed immediately. Sputum samples
were divided into two equal aliquots: one for bacterial
culture and another was stored at 20°C for real-time
reverse transcriptase PCR ([RT]-qPCR) testing. The OPS
was used to sample the posterior oropharyngeal mucosal
membrane using a commercial rigid cotton-tipped swab
(MWE, Wiltshire, UK). After swabbing, the OPS specimens
were placed in 15 ml virus transport medium (Gly
medium) and stored at 20°C before performing qPCR
assays.
Diagnostics
The sputum samples and blood samples were cultured
according to standard microbiological procedures. All spu-
tum samples were examined by microscopy, and sputum
samples with the presence of >25 polymorphonuclear
leukocytes and <10 squamous cells per field were considered
to be acceptable for culture. Significant bacterial growth of
the sputum sample was defined as growth of a predominant
organism on the culture plates and compatible results from
Gram stain.
Urine sample were tested by urinary antigen detection
tests for S. pneumoniae and L. pneumophila (BinaxNOW
pneumococcal urinary antigen test and the BinaxNOW
Legionella urinary antigen test, Alere, Portland, ME, USA).
All oropharyngeal and sputum samples were tested by (RT)-
qPCR for the presence of respiratory viruses and bacteria
including AdV, human bocavirus (HBoV), KI polyomavi-
ruses and WU polyomaviruses (KIPyV and WUPyV), human
metapneumovirus (hMPV), human rhinovirus (HRV),
human coronaviruses (HCoV) (OC43, NL63, HKU1, and
229E), parainfluenza viruses (PIV)14, influenza viruses A
and B (InfA, InfB), RSV, L. pneumophila, M. pneumoniae,
Chlamydophila psittaci, Chlamydophila pneumoniae, and
Coxiella burnetii. Serum samples were tested for the presence
of C. burnetii. (RT)-qPCR procedures were performed as
described.13–19 (RT)-qPCR results were expressed in cycle
threshold-values.
Statistical analysis
A consensus standard was used to assess the sensitivity of the
OPS or sputum sample: A positive result in either the OPS or
sputum sample was considered as the gold standard for the
presence of a pathogen and was used to calculate the
sensitivity of the OPS or sputum sample for the detection of
the respiratory pathogens. McNemar’s test was used to assess
the significance of the difference between two correlated
proportions. Analyses were conducted using PASW Statistics
18 (IBM Company, Chicago, VS, USA).
Results
Characteristics
Of the 408 patients with CAP that were evaluated during
the study period, a subset of 115 (282%) met the inclusion
criteria for completeness of sampling and was included in
the study. Patients ranged in age from 20 to 90 years (mean
66 years), 62% of the patients were male. Thirty-two
(278%) patients had had antibiotic treatment prior to
admission.
Microbiological yield
Using conventional methods, that is, blood cultures, sputum
culture, urinary antigen tests, 57 patients (496%) tested
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positive for at least one pathogen. Adding the full molecular
diagnostic package increased the diagnostic yield to 80%. The
most frequently detected bacterial pathogens were S. pneu-
moniae (n = 27) and C. burnetii (n = 13). In 14 patients,
S. pneumoniae was the only detected pathogen, and in six
patients, C. burnetii was the only detected pathogen. The
most frequently isolated viral pathogens were HRV (n = 13)
and PIV1 (n = 8). In the majority of patients, HRV and PIV1
were detected in combination with other pathogens. In 58
patients (504%), only one pathogen was detected. Mixed
infections were common, with up to three possible pathogens
listed (Table 1).
The majority of patients with mixed infections had
S. pneumoniae identified. S. pneumoniae was detected in 14
blood cultures, 20 urinary antigen tests, and five sputum
samples.
Haemophilus influenzae, Moraxella catarrhalis, and Staph-
ylococcus aureus were only detected in sputum cultures.
Escherichia coli and other Gram-negative bacteria were
isolated from blood cultures and sputum cultures. Pseudo-
monas aeruginosa was only isolated from a blood culture.
Beside qPCR on OPS and sputum samples, L. pneumophila
was also detected with the urinary antigen test in three
patients. These patients had also a positive qPCR on OPS
and/or sputum samples. Coxiella burnetii was detected in
four serum samples; these patients had also qPCR-positive
sputum samples (Figure 1).
Sensitivity of molecular diagnostics on OPS and
sputum samples
A positive qPCR in OPS and/or sputum samples was found
in 77 of the 115 patients. For 33 (429%) of the 77 patients,
the pathogens were only detected in the sputum sample,
while for 20 (260%) of them, the pathogens were only
detected in the OPS. KIPyV, WUPyV, HCoV HKU1, and
HCoV 229E were only detected in the OPS, whereas
C. psittaci was uniquely found in sputum (Table 2). The
sensitivity for detecting any pathogen was 57% (95%CI: 45–
68) using OPS and 74% using sputum (95%CI: 63–83).
Bacterial pathogens were more often detected in sputum
samples than in OPS (92%, 95%CI: 72–99 versus 25%, 95%
CI: 11–47, P < 0001). Except for HRV and RSV, the
sensitivity for the detection of viruses using OPS was higher
compared with the use of sputum samples (72%, 95%CI: 57–
83 versus 66%, 95%CI: 52–78, P = 069).
Discussion
This study demonstrates that a possible etiological diagnosis
can be found in a high proportion (80%) of patients with
Table 1. Diagnostic yield in 92 patients with CAP
Single pathogen (n = 58) 2 pathogens (n = 25) 3 pathogens (n = 9)
14 Streptococcus pneumoniae 5 S. pneumoniae+HRV 1 S. pneumoniae+InfA+GNB
6 Coxiella burnetii 1 S. pneumoniae+GNB 1 S. pneumoniae+Haemophilus influenzae+RSV
6 GNB 1 S. pneumoniae+C. burnetii 1 H. influenzae+C. burnetii+HCoV OC43
5 H. influenzae 1 S. pneumoniae+InfA 1 H. influenzae+RSV+KIPyV
3 Staphylococcus aureus 1 S. pneumoniae+PIV1 1 Legionella pneumophila+PIV1+GNR
3 HRV 1 S. pneumoniae+HCoV OC43 1 PIV1+HRV+HCoV NL63
3 InfA 1 S. pneumoniae+HCoV NL63 1 InfB+WU+HCoV NL63
3 RSV 1 L. pneumophila+InfB 1 S. aureus+P. aeruginosa+HCoV 229E
2 Chlamydophila psittaci 1 L. pneumophila+HRV 1 C. burnetii+HCoV 229E+HCoV OC43
2 L. pneumophila 1 L. pneumophila+C. burnetii
2 HCoV OC43 1 L. pneumophila+M. pneumoniae
2 PIV1 1 C. burnetii+HRV
1 E. coli 1 C. burnetii+S. milleri
1 Moraxella catarrhalis 1 C. burnetii+E. coli
1 P. luteola 1 C. psittaci+S. aureus
1 AdV 1 E. coli+HRV
1 InfB 1 InfA+H. influenzae
1 HCoV 229E 1 PIV1+H. influenzae
1 hMPv 1 PIV1+HCoV HKU
1 PIV1+PIV3
1 PIV3+HRV
AdV, adenovirus; KIPyV, KI polyomavirus; WUPyV, WU polyomavirus; hMPV, human metapneumovirus; HRV, human rhinovirus; HCoV OC43, NL63,
HKU1 and 229E, human coronaviruses; PIV1–4, parainfluenza viruses 1–4; InfA, influenza A virus; InfB, influenza B virus; RSV, respiratory syncytial
virus; GNB, Gram-negative bacteria; CAP, community-acquired pneumonia.
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Figure 1. Detection of pathogens in patients with CAP by material. GNB, Gram-negative bacteria; CAP, community-acquired pneumonia; X: method not
used or suitable for detection of specific pathogen.
Table 2. Detection of respiratory pathogens and the sensitivity by OPS and sputum sample
Pathogens detected in:
Both sputum
and OPS OPS only Sputum only Total
OPS sensitivity
95% CI
Sputum
sensitivity 95% CI
Bacteria
Legionella pneumophila 1 0 6 7 14 (0–58) 100 (56–100)
Mycoplasma pneumoniae 1 0 0 1 100 (5–100) 100 (5–100)
Coxiella burnetii 2 2 9 13 36 (12–68) 85 (54–97)
Chlamydophila psittaci 0 0 3 3 0 (0–69) 100 (31–100)
Chlamydophila pneumoniae 0 0 0 0 – –
Total bacteria 4 2 18 24 25 (11–47) 92 (72– 99)
Viruses
Adenovirus 1 0 0 1 100 (5–100) 100 (5–100)
Human bocavirus 0 0 0 0 – –
KI polyomavirus 0 1 0 1 100 (5–100) 0 (0–95)
WU polyomavirus 0 1 0 1 100 (5–100) 0 (0–95)
Human metapneumovirus 1 0 0 1 100 (5–100) 100 (5–100)
Human rhinovirus 3 0 10 13 23 (6–54) 100 (72–100)
Human coronaviruses
OC43 5 0 0 5 100 (46–100) 100 (46–100)
NL63 1 2 0 3 100 (31–100) 33 (2–87)
HKU1 0 1 0 1 100 (5–100) 0 (0–95)
229E 0 3 0 3 100 (31–100) 0 (0–69)
Parainfluenza viruses
1 0 7 1 8 88 (47–99) 13 (1–53)
2 0 0 0 0 – –
3 1 0 1 2 50 (3–97) 100 (20–100)
4 0 0 0 0 – –
Influenza A virus 6 0 0 6 100 (52–100) 100 (52–100)
Influenza B virus 1 2 0 3 100 (31–100) 33 (2–87)
Respiratory syncytial virus 1 1 3 5 40 (7–83) 80 (30–99)
Total viruses 20 18 15 53 72 (57–83) 66 (52– 78)
Total 24 20 33 77 57 (45–68) 74 (63–83)
OPS, oropharyngeal swab, CI, confidence interval.
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CAP, when optimal sampling and a broad diagnostic package
are used.
The reality of clinical practice is that the majority of
patients with CAP undergo limited diagnostic tests to
demonstrate an etiological agent, other than urine antigen
test and, only if available, a bacterial sputum culture. Good
quality sputum samples are obtained in 40–60% of patients
with CAP, but the diagnostic yield using the classical
methods (culture) may be limited. In our study, a bacterial
pathogen was cultured from 27% of the sputum samples,
slightly higher than was found in published reports
(9–144%).8,9,20
Isolation of atypical respiratory bacterial pathogens, for
example M. pneumoniae, C. pneumoniae is difficult because
these pathogens are hardly culturable and cell culture is time-
consuming.
In our study, the use of qPCR on sputum samples
increased the yield significantly for these pathogens; OPS
were not suitable for the detection of them.
Respiratory viruses are poorly detected by conventional
techniques.21 Rapid assessment of viruses is now possible
with sensitive and highly specific real-time PCR assays, but
the utility of swabs versus washes and nose versus oropha-
ryngeal versus nasopharyngeal samples is subject to consid-
erable debate. Lieberman et al.22 found that viral pathogens
are better detected by nasopharyngeal washes as they offer a
better yield than nasal or OPS, but this procedure is poorly
tolerated and rarely used in hospitalized patients. On the
other hand, de la Tabla et al.23 reported that a combined
nose–throat swab was superior to nasopharyngeal aspirates
for the detection of InflA (H1N1) and that the combination
of both methods increases the detection rate. In our study,
we used a sputum sample and OPS for the detection of viral
pathogens and found that OPS was equally or more sensitive
for most viruses except HRV and RSV. Falsey et al.24 found
in their study that more viruses were detected in sputum
samples compared with nose–throat swabs, 44% of the
viruses were detected by both methods, 23% were positive by
nose–throat swabs alone, and 33% were positive only with
sputum samples. Similar to our study, nose–throat swabs and
sputum testing yield complementary results. For bacterial
pathogens, sputum samples clearly were superior to OPS.
Similar to studies elsewhere, we found S. pneumoniae as the
most common potential pathogen.1,25 In the literature,
S. pneumoniae PCR on sputum samples as a diagnostic tool
for pneumococcal CAP has had mixed results because
distinguishing colonization from infection is difficult even
by quantifying the load.26–29 However, patients with CAP
tend to be more frequently colonized with pneumococci than
asymptomatic patients and an important hypothesis is that
aspiration of oropharyngeal contents the most common
route is of developing pneumonia.30–32 Similarly, culturing
Streptococci from sputum samples are not conclusive
evidence for their etiological role. Therefore, the value of
routine detection of S. pneumoniae remains a matter of
debate. Similar to others, our study showed that molecular
detection of L. pneumophila on sputum could replace
urinary antigen testing.33,34 Practically, however, this requires
a laboratory setup capable of providing such diagnostics with
a rapid turnaround time, and 24/7, a situation that is
currently not achievable in many settings.
In our study population, a relatively large number of
C. burnetii in patients with CAP were found. This was due to
a Q fever outbreak in our area with over 4000 notified cases
in the Netherlands between 2007 and 2010.35 For viruses,
results comparing sample types were more variable: Overall,
based on our data and the convenience of the sampling
procedure, OPS would be the preferred sample type, with the
exception of HRV and RSV. Our findings are in agreement
with published studies focusing on viral pathogens as
primary causes of CAP remain an issue of considerable
debate.21,36,37 The majority of patients with CAP positive for
HRV had a second respiratory virus or a bacterial pathogen,
and HCoVs were never found as a single infection. In
addition, HRV are highly prevalent, and case–control studies
have also found HRV to be common in asymptomatic
persons as well.21,36 Our findings do suggest, however, that IF
these pathogens are included in the diagnostic package and
HRV testing should be integrated in a sputum panel,
consisting of bacterial targets in addition to HRV and RSV.
This may be more relevant for RSV for which therapeutic
options are available, although the efficacy of antivirals in
this patient category remains to be determined.38
Limitations in our study include the lack of a control
group to determine the prevalence of respiratory pathogens.
More than one pathogen was isolated in 34 (26%) of the 115
patients and in nine patients three pathogens were found.
Real-time PCR significantly improves the sensitivity of
detecting pathogens, and often it is not possible to determine
the contribution of each pathogen as the detection of viral or
bacterial nucleic acids may not always represent causation. In
a study by van Gageldonk et al.39, in approximately 20% of
the subjects with no respiratory complaints, respiratory viral
pathogens were detected. On the other hand, Lieberman
et al.22 found a much lower prevalence (71%) of respiratory
viruses in subjects with no respiratory complaints. In this
study, all subjects enrolled were symptomatic, and this would
increase the likelihood that isolated pathogens were causa-
tive, unfortunately observational cohort studies such as this
are not able to directly determine causation. Quantitative
(RT)-qPCR data would have been useful to help address the
question whether there is active infection in the lower
respiratory tract instead of detecting residual DNA/RNA
from a prior infection or asymptomatic carriage. Finally, we
only included a subset of patients with CAP, but we have no
reason to believe that the patients who were not included
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would be substantially different compared with the study
group.
Conclusions
Based on our findings, providing a targeted bacterial PCR
package for sputum testing and a separate viral package for
OPS testing would provide almost the same diagnostic yield
as the full spectrum of tests used in the study. This would
only be feasible if results of PCR can be available with very
short turnaround time. When looking at diagnostic yield, the
sputum package could include HRV and RSV testing. While
this would lead to a potential diagnosis in a high proportion
of CAP patients, a critical appraisal of the added value of the
expanding diagnostic packages is needed, given the costs of
such procedures. Studies are needed to evaluate the impact of
testing algorithms on patient treatment and outcome.
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